Caltagirone C

References (13)

Title : Gender Differences in Neuropsychiatric Symptoms in Mild to Moderate Alzheimer's Disease Patients Undergoing Switch of Cholinesterase Inhibitors: A Post Hoc Analysis of the EVOLUTION Study - Colombo_2018_J.Womens.Health.(Larchmt)_27_1368
Author(s) : Colombo D , Caltagirone C , Padovani A , Sorbi S , Spalletta G , Simoni L , Ori A , Zagni E
Ref : J Womens Health (Larchmt) , 27 :1368 , 2018
Abstract :
PubMedSearch : Colombo_2018_J.Womens.Health.(Larchmt)_27_1368
PubMedID: 30085899

Title : Myeloid dendritic cells are decreased in peripheral blood of Alzheimer's disease patients in association with disease progression and severity of depressive symptoms - Ciaramella_2016_J.Neuroinflammation_13_18
Author(s) : Ciaramella A , Salani F , Bizzoni F , Orfei MD , Caltagirone C , Spalletta G , Bossu P
Ref : J Neuroinflammation , 13 :18 , 2016
Abstract :
PubMedSearch : Ciaramella_2016_J.Neuroinflammation_13_18
PubMedID: 26811068

Title : Cognitive and affective changes in mild to moderate Alzheimer's disease patients undergoing switch of cholinesterase inhibitors: a 6-month observational study - Spalletta_2014_PLoS.One_9_e89216
Author(s) : Spalletta G , Caltagirone C , Padovani A , Sorbi S , Attar M , Colombo D , Cravello L
Ref : PLoS ONE , 9 :e89216 , 2014
Abstract :
PubMedSearch : Spalletta_2014_PLoS.One_9_e89216
PubMedID: 24586603

Title : Altered parietal-motor connections in Alzheimer's disease patients - Bonni_2013_J.Alzheimers.Dis_33_525
Author(s) : Bonni S , Lupo F , Lo Gerfo E , Martorana A , Perri R , Caltagirone C , Koch G
Ref : J Alzheimers Dis , 33 :525 , 2013
Abstract :
PubMedSearch : Bonni_2013_J.Alzheimers.Dis_33_525
PubMedID: 23001709

Title : A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease - Di Santo_2013_J.Alzheimers.Dis_35_349
Author(s) : Di Santo SG , Prinelli F , Adorni F , Caltagirone C , Musicco M
Ref : J Alzheimers Dis , 35 :349 , 2013
Abstract :
PubMedSearch : Di Santo_2013_J.Alzheimers.Dis_35_349
PubMedID: 23411693

Title : Brain tissue modifications induced by cholinergic therapy in Alzheimer's disease - Bozzali_2013_Hum.Brain.Mapp_34_3158
Author(s) : Bozzali M , Parker GJ , Spano B , Serra L , Giulietti G , Perri R , Magnani G , Marra C , M GV , Caltagirone C , Cercignani M
Ref : Hum Brain Mapp , 34 :3158 , 2013
Abstract :
PubMedSearch : Bozzali_2013_Hum.Brain.Mapp_34_3158
PubMedID: 22711258

Title : Rivastigmine Patch Ameliorates Depression in Mild AD: Preliminary Evidence From a 6-Month Open-label Observational Study - Spalletta_2013_Alzheimer.Dis.Assoc.Disord_27_289
Author(s) : Spalletta G , Gianni W , Giubilei F , Casini AR , Sancesario G , Caltagirone C , Cravello L
Ref : Alzheimer Disease & Associated Disorders , 27 :289 , 2013
Abstract :
PubMedSearch : Spalletta_2013_Alzheimer.Dis.Assoc.Disord_27_289
PubMedID: 22760171

Title : The role of persistent and incident major depression on rate of cognitive deterioration in newly diagnosed Alzheimer's disease patients - Spalletta_2012_Psychiatry.Res_198_263
Author(s) : Spalletta G , Caltagirone C , Girardi P , Gianni W , Casini AR , Palmer K
Ref : Psychiatry Res , 198 :263 , 2012
Abstract :
PubMedSearch : Spalletta_2012_Psychiatry.Res_198_263
PubMedID: 22406390

Title : Anatomical connectivity mapping: a new tool to assess brain disconnection in Alzheimer's disease - Bozzali_2011_Neuroimage_54_2045
Author(s) : Bozzali M , Parker GJ , Serra L , Embleton K , Gili T , Perri R , Caltagirone C , Cercignani M
Ref : Neuroimage , 54 :2045 , 2011
Abstract :
PubMedSearch : Bozzali_2011_Neuroimage_54_2045
PubMedID: 20828625

Title : Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) patients are characterized by increased BDNF serum levels - Angelucci_2010_Curr.Alzheimer.Res_7_15
Author(s) : Angelucci F , Spalletta G , di Iulio F , Ciaramella A , Salani F , Colantoni L , Varsi AE , Gianni W , Sancesario G , Caltagirone C , Bossu P
Ref : Curr Alzheimer Res , 7 :15 , 2010
Abstract :
PubMedSearch : Angelucci_2010_Curr.Alzheimer.Res_7_15
PubMedID: 20205668

Title : Rivastigmine in Alzheimer's disease: Cognitive function and quality of life - Annicchiarico_2007_Ther.Clin.Risk.Manag_3_1113
Author(s) : Annicchiarico R , Federici A , Pettenati C , Caltagirone C
Ref : Ther Clin Risk Manag , 3 :1113 , 2007
Abstract :
PubMedSearch : Annicchiarico_2007_Ther.Clin.Risk.Manag_3_1113
PubMedID: 18516265

Title : Guidelines for the treatment of Alzheimer's disease from the Italian Association of Psychogeriatrics - Caltagirone_2005_Drugs.Aging_22 Suppl 1_1
Author(s) : Caltagirone C , Bianchetti A , Di Luca M , Mecocci P , Padovani A , Pirfo E , Scapicchio P , Senin U , Trabucchi M , Musicco M
Ref : Drugs & Aging , 22 Suppl 1 :1 , 2005
Abstract :
PubMedSearch : Caltagirone_2005_Drugs.Aging_22 Suppl 1_1
PubMedID: 16506439

Title : Clinical pharmacology of anti-Alzheimer drugs - Pettenati_2003_Fundam.Clin.Pharmacol_17_659
Author(s) : Pettenati C , Annicchiarico R , Caltagirone C
Ref : Fundamental & Clinical Toxicology , 17 :659 , 2003
Abstract :
PubMedSearch : Pettenati_2003_Fundam.Clin.Pharmacol_17_659
PubMedID: 15015711